Ellipse Technologies files $75M IPO: 4 takeaways

Ellipse Technologies has filed for an initial public offering of up to $75 million.

Advertisement

Here are four takeaways:

 

1. The company develops and markets a pipeline of magnetically adjustable implant systems, including the MAGEC-EOS spinal bracing and distraction system and PRECICE limb lengthening system.

 

2. The MAGEC system is intended for treatment of early onset scoliosis and the PRECICE system for treatment of limb length discrepancy.

 

3. Both systems incorporate the company’s proprietary MAGnetic External Control technology.

 

4. Ellipse Technologies estimates that the global addressable market opportunity for its products was approximately $1.2 billion in 2014.

 

More articles on devices:
Soft Tissue Regeneration launches L-C Ligament clinical trial — 5 takeaways
Dr. Charles Brooker implants permanent spinal cord stimulator in Australia: 5 things to know
InVivo’s pilot study expands to 10 spinal cord injury patients — 5 key notes

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.